Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of oral alitretinoin in palmo-plantar pustulosis
2010-022843-39Phase 2Completed
- Sponsor
- GSK
- Start
- Nov 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of alitretinoin in Palmoplantar Pustular Psoriasis (PPPP), sponsored by GSK. Primary endpoint: PPPASI response at week 24. Started Nov 2010; status: completed.
02
Drugs
alitretinoin
03
Conditions
Palmoplantar Pustular Psoriasis (PPPP)
Beyond the preview
Go deeper on 2010-022843-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022843-39.